Ellis Shareholders' Meeting: Heavy reliance on a single blockbuster product, with more growth anxieties to address amid the looming patent cliff.

① Once the growth dividend of Fumetinib begins to taper off, whether there will be a successor product and where Alis's "next Fumetinib" lies have become key focal points for the market; ② The domestic patent for the Fumetinib compound is set to expire in 2034, while the domestic patent for Methanesulfonic Acid Fumetinib (salt) will expire in 2036. **This implies that the existing patent protection barrier will vanish by then, and Alis may no longer enjoy the high gross profit margin associated with its original drug.**

cls.cn51minutes ago

Smart glasses are being tailored for vertical scenarios, while the killer application is still in development.

①Reporters observed at the 2026 Shanghai VR/AR Industry Expo that, unlike the bustling atmosphere of争相首发 and parameter competition during the early stages of the 'hundred mirrors battle,' companies this year have shifted their focus to vertical application scenarios such as industry, healthcare, and office environments. ②Although the industry has moved past the concept validation phase, the widely recognized 'killer application' is still forthcoming, and the depth and essential nature of application scenarios may become the key factors determining the next stage of industry development.

cls.cn52minutes ago

The electronic chemicals sector ranks among the top in terms of gains, with storage chip-related stocks remaining highly active.

① This week, the three major A-share indices showed mixed performance, with the ChiNext Index surging 3.50% on a weekly basis, reaching a new all-time high; ② The electronic chemicals sector led the gains, with Zhongchuan Special Gas rising 82.30% over the week; ③ Stocks related to memory chips remained highly active, driven by the rapid expansion of AI computing infrastructure, which may continue to push memory chip prices higher.

cls.cn14:16

The 'Token Factory' achieves real-world implementation: Operators initiate large-scale procurement worth tens of billions, while major companies accelerate their strategic positioning.

① Ningxia Branch of China Telecom released the centralized procurement project for the "Token Factory" generation capability service, marking the first large-scale procurement project named after the Token Factory among the three major telecom operators, valued at the billion-dollar level. ② The Token Factory is considered "the business model with the fastest short-term growth for model vendors and the most certain commercialization potential in its early stages." ③ Baidu recently announced that Baidu Intelligent Cloud will upgrade its "MaaS Model Service" to the "Token Factory."

cls.cn13:42

Jinhai High-Tech transfers ownership for 1.452 billion yuan to gaming tycoon: Stock price surged before trading halt, SSE initiates regulatory investigation | Express Announcement

① The company undertakes that, following this change of control, it will not engage in any gaming-related business activities or acquire any gaming-related assets, and this undertaking shall remain valid indefinitely; ② This change in control represents a typical case where a privately held family-owned enterprise opts for capital exit following intergenerational succession; ③ The close ties formed through intertwined equity and personnel relationships constitute the common background underpinning Jin Danliang and Chen Yongcong’s status as acting-in-concert parties.

cls.cn13:39

Publicly offered funds collectively 'chase the light,' with over a hundred public funds researching New Easy Prosperity.

①Chuangjin Hexin topped the research rankings, having conducted 637 surveys year-to-date, covering 534 individual stocks; ②New Easun, the leader in optical modules, has become a “popular stock,” attracting over a hundred public funds to conduct surveys; ③Public funds have focused their research on AI computing hardware supply chains such as optical modules, strengthening the consensus on hard technology.

cls.cn10:29